ArticleWorld journal of surgical oncology2023

Durable response to afatinib in advanced lung adenocarcinoma harboring a novel NPTN-NRG1 fusion: a case report.

Xin Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.